Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
22.84
+0.48 (2.15%)
Jan 21, 2025, 4:00 PM EST - Market closed
Pacira BioSciences Employees
As of December 31, 2023, Pacira BioSciences had 712 total employees, including 711 full-time and 1 part-time employees. The number of employees decreased by 3 or -0.42% compared to the previous year.
Employees
712
Change (1Y)
-3
Growth (1Y)
-0.42%
Revenue / Employee
$976,063
Profits / Employee
-$127,431
Market Cap
1.05B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PCRX News
- 10 hours ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira Lawsuit – PCRX - GlobeNewsWire
- 11 hours ago - The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against Pacira BioSciences, Inc. - Accesswire
- 1 day ago - Pacira BioSciences, Inc. Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
- 1 day ago - Pacira BioSciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - PCRX - PRNewsWire
- 5 days ago - Pacira BioSciences, Inc. Is Being Sued For Securities Law Violations And Impacted Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
- 5 days ago - Pacira BioSciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before March 14, 2025 to Discuss Your Rights - PCRX - PRNewsWire
- 6 days ago - SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira - PRNewsWire
- 6 days ago - The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against Pacira BioSciences Inc - Accesswire